Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

PAPERS
[View FULLTEXT] [Download PDF
 
Year : 1992  |  Volume : 38  |  Issue : 3  |  Page : 124-6  

Effect of ipratropium bromide in bronchial asthma.

V Taskar, L Mirchandani, AA Mahashur, RR Sharma, VP Kolhatkar 
 Dept of Respiratory Medicine, KEM Hospital, Parel, Bombay, Maharashtra.

Correspondence Address:
V Taskar
Dept of Respiratory Medicine, KEM Hospital, Parel, Bombay, Maharashtra.

The effect of inhalation of ipratropium bromide was evaluated in 20 patients with bronchial asthma. It was observed that there was no significant improvement in the forced vital capacity and the forced expired volume in one second, while there was significant improvement in the peak expiratory flow rate (PEFR) measured at 9 pm, after inhalation of 2 puffs of ipratropium bromide aerosol (0.02mg/puff) three to four times a day for 2 weeks. Since PEFR is a measure of large airway function and cholinergic mechanisms are primarily involved for airflow obstruction at large airways, improvement in PEFR by ipratropium bromide highlights its role as a useful bronchodilator in patients in whom vagal reflexes are responsible for the provocation of bronchoconstriction.


How to cite this article:
Taskar V, Mirchandani L, Mahashur A A, Sharma R R, Kolhatkar V P. Effect of ipratropium bromide in bronchial asthma. J Postgrad Med 1992;38:124-6


How to cite this URL:
Taskar V, Mirchandani L, Mahashur A A, Sharma R R, Kolhatkar V P. Effect of ipratropium bromide in bronchial asthma. J Postgrad Med [serial online] 1992 [cited 2022 Jan 29 ];38:124-6
Available from: https://www.jpgmonline.com/article.asp?issn=0022-3859;year=1992;volume=38;issue=3;spage=124;epage=6;aulast=Taskar;type=0


 
Saturday, January 29, 2022
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer